Download this Paper Open PDF in Browser

Cognition-Enhancing Drugs: Can We Say No?

Bulletin of Science, Technology & Society, Vol. 30, No. 9, 2010

6 Pages Posted: 15 Jun 2010  

Frank A. Pasquale III

University of Maryland Francis King Carey School of Law; Yale University - Yale Information Society Project

Date Written: June 14, 2010

Abstract

Normative analysis of cognition-enhancing drugs frequently weighs the liberty interests of drug users against egalitarian commitments to a "level playing field." Yet those who would refuse to engage in neuroenhancement may well find their liberty to do so limited in a society where such drugs are widespread. To the extent that unvarnished emotional responses are world-disclosive, neurocosmetic practices also threaten to provide a form of faulty data to their users. This essay examines underappreciated liberty-based and epistemic rationales for regulating cognition-enhancing drugs.

Keywords: cognition-enhancing drugs

Suggested Citation

Pasquale, Frank A., Cognition-Enhancing Drugs: Can We Say No? (June 14, 2010). Bulletin of Science, Technology & Society, Vol. 30, No. 9, 2010. Available at SSRN: https://ssrn.com/abstract=1625028 or http://dx.doi.org/10.2139/ssrn.1625028

Frank A. Pasquale III (Contact Author)

University of Maryland Francis King Carey School of Law ( email )

500 West Baltimore Street
Baltimore, MD 21201-1786
United States
410-706-4820 (Phone)
410-706-0407 (Fax)

Yale University - Yale Information Society Project ( email )

127 Wall Street
New Haven, CT 06511
United States

Paper statistics

Downloads
135
Rank
179,448
Abstract Views
1,233